The role of immunosuppression in recurrence of hepatitis C
- 30 November 2003
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 9 (11), S63-S66
- https://doi.org/10.1053/jlts.2003.50264
Abstract
Key points 1. Recurrent hepatitis C is an increasing problem posttransplantation. 2. It is difficult to determine histologically if alloimmunity, i.e., rejection, is also plays a role in posttransplantation hepatitis C. 3. Change in the degree of immunosuppression, rather than the absolute amount of immunosuppression, is bad for HCV‐infected recipients. 4. Corticosteroid boluses are bad for HCV‐infected recipients.Keywords
This publication has 19 references indexed in Scilit:
- Lack of antiviral effect of a short course of mycophenolate mofetil in patients with chronic hepatitis C virus infectionLiver Transplantation, 2003
- Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantationLiver Transplantation, 2002
- Hepatitis C and mycophenolate mofetil[mdash ]a clarificationLiver Transplantation, 2002
- Immunoprophylaxis with basiliximab, a chimeric anti[ndash ]interleukin-2 receptor monoclonal antibody, in combination with azathioprine-containing triple therapy in liver transplant recipientsLiver Transplantation, 2002
- Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trialLiver Transplantation, 2002
- A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis CLiver Transplantation, 2002
- Anti[ndash ]Interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantationLiver Transplantation, 2001
- Editorial: Steroid-free immunosuppression: Balancing efficacy and toxicityLiver Transplantation, 2001
- A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipientsLiver Transplantation, 2001
- Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantationHepatology, 1995